ThermoGenesis Holdings Inc. (NASDAQ:THMO)’s traded shares stood at 4.99 million during the last session, with the company’s beta value hitting 2.59. At the close of trading, the stock’s price was $5.05, to imply a decrease of -15.83% or -$0.95 in intraday trading. The THMO share’s 52-week high remains $40.49, putting it -701.78% down since that peak but still an impressive 58.22% since price per share fell to its 52-week low of $2.11. The company has a valuation of $5.81M, with an average of 5.93 million shares in intraday trading volume over the past 10 days and average of 1.10 million shares over the past 3 months.
ThermoGenesis Holdings Inc. (NASDAQ:THMO) trade information
After registering a -15.83% downside in the last session, ThermoGenesis Holdings Inc. (THMO) has traded red over the past five days. The stock hit a weekly high of 6.67 this Friday, 03/17/23, dropping -15.83% in its intraday price action. The 5-day price performance for the stock is 123.45%, and 36.49% over 30 days. With these gigs, the year-to-date price performance is 57.81%. Short interest in ThermoGenesis Holdings Inc. (NASDAQ:THMO) saw shorts transact 15510.0 shares and set a 0.1 days time to cover.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Analysts on Wall Street suggest a consensus price target of $45.00, implying an increase of 88.78% to the stock’s current value. The extremes give us $45.00 and $45.00 for target low and target high price respectively. As such, THMO has been trading -791.09% off suggested target high and -791.09% from its likely low.
ThermoGenesis Holdings Inc. (THMO) estimates and forecasts
Revenue is forecast to grow 94.70% this quarter before jumping 93.30% for the next one. The rating firms project that company’s revenue will grow 23.10% compared to the previous financial year.
Revenue forecast for the current quarter as set by 1 analysts is $2.89 million. Meanwhile, for the quarter ending Mar 2023, a total of 1 analyst(s) estimate revenue growth to $4.5 million.Earnings reports from the last fiscal year show that sales brought in $2.42 million and $2.66 million respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 19.50% before jumping 69.00% in the following quarter.
ThermoGenesis Holdings Inc. has its next earnings report out between March 27 and March 31. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. ThermoGenesis Holdings Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
ThermoGenesis Holdings Inc. (NASDAQ:THMO)’s Major holders
ThermoGenesis Holdings Inc. insiders hold 26.32% of total outstanding shares, with institutional holders owning 1.30% of the shares at 1.77% float percentage. In total, 1.30% institutions holds shares in the company, led by Renaissance Technologies, LLC. As of Sep 29, 2022, the company held over 3467.0 shares (or 0.33% of shares), all amounting to roughly $38754.0.
The next major institution holding the largest number of shares is Vanguard Group, Inc. (The) with 2708.0 shares, or about 0.26% of shares outstanding. As of the market price on Sep 29, 2022, these shares were worth $30270.0.
We also have Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the ThermoGenesis Holdings Inc. (THMO) shares. Going by data provided on Sep 29, 2022, Vanguard Extended Market Index Fund holds roughly 2708.0 shares. This is just over 0.26% of the total shares, with a market valuation of $30270.0. Data from the same date shows that the other fund manager holds a little less at 707.0, or 0.07% of the shares, all valued at about 4533.0.